ReviewAnnals of hematology2022
A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review.
Mohammad Vaezi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.